These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35529064)

  • 21. Ritonavir Form III: A New Polymorph After 24 Years.
    Yao X; Henry RF; Zhang GGZ
    J Pharm Sci; 2023 Jan; 112(1):237-242. PubMed ID: 36195132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New solvates of an old drug compound (phenobarbital): structure and stability.
    Zencirci N; Griesser UJ; Gelbrich T; Kahlenberg V; Jetti RK; Apperley DC; Harris RK
    J Phys Chem B; 2014 Mar; 118(12):3267-80. PubMed ID: 24571055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorph screening of an active material.
    Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
    J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ethanol on physical state of freeze-dried mannitol.
    Takada A; Nail SL; Yonese M
    Pharm Res; 2009 May; 26(5):1112-20. PubMed ID: 19184373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound assisted nucleation and growth characteristics of glycine polymorphs--a combined experimental and analytical approach.
    Renuka Devi K; Raja A; Srinivasan K
    Ultrason Sonochem; 2015 May; 24():107-13. PubMed ID: 25465875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase transformation in conformational polymorphs of nimesulide.
    Sanphui P; Sarma B; Nangia A
    J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ritonavir: an extraordinary example of conformational polymorphism.
    Bauer J; Spanton S; Henry R; Quick J; Dziki W; Porter W; Morris J
    Pharm Res; 2001 Jun; 18(6):859-66. PubMed ID: 11474792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of sulindac: isolation and characterization of a new polymorph and three new solvates.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    J Pharm Sci; 1997 Feb; 86(2):248-51. PubMed ID: 9040104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallization, spectral, crystallographical, and thermoanalytical studies of succinobucol polymorphism.
    Jurček O; Lahtinen M; Wimmer Z; Drašar P; Kolehmainen E
    J Pharm Sci; 2012 May; 101(5):1794-802. PubMed ID: 22323097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and crystallographic analysis of gliclazide polymorphs.
    Rajamma AJ; Sateesha SB; Narode MK; Prashanth VR; Karthik AM
    Indian J Pharm Sci; 2015; 77(1):34-40. PubMed ID: 25767316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling the crystal polymorph by exploiting the time dependence of nucleation rates.
    Little LJ; King AAK; Sear RP; Keddie JL
    J Chem Phys; 2017 Oct; 147(14):144505. PubMed ID: 29031253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational study of metformin hydrochloride nucleation in hydroxylic solvents: Experimental kinetics and DFT simulation.
    Gu X; Si Z; Yan Y; Zhang X
    Int J Pharm; 2022 Mar; 616():121517. PubMed ID: 35104599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-liquid phase diagrams for the determination of the solid state nature of both polymorphs of (RS)-2-(2-oxo-pyrrolidin-1-yl)-butyramide.
    Herman C; Haut B; Aerts L; Leyssens T
    Int J Pharm; 2012 Nov; 437(1-2):156-61. PubMed ID: 22846407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and physicochemical characterization of caffeine-citric acid co-crystal polymorphs.
    Mukaida M; Watanabe Y; Sugano K; Terada K
    Eur J Pharm Sci; 2015 Nov; 79():61-6. PubMed ID: 26360836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.
    Araya-Sibaja AM; Soldi V; Campos CE; Cardoso SG; Cuffini SL
    Drug Dev Ind Pharm; 2015 May; 41(5):851-8. PubMed ID: 24758712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular simulation of cross-nucleation between polymorphs.
    Desgranges C; Delhommelle J
    J Phys Chem B; 2007 Feb; 111(6):1465-9. PubMed ID: 17243668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of febuxostat polymorphs using powder X-ray diffraction technique.
    Qiu JB; Li G; Sheng Y; Zhu MR
    J Pharm Biomed Anal; 2015 Mar; 107():298-303. PubMed ID: 25636167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Solvent Stabilization on Pharmaceutical Crystallization: Investigating Conformational Polymorphism of Probucol Using Combined Solid-State Density Functional Theory, Molecular Dynamics, and Terahertz Spectroscopy.
    Rexrode NR; Orien J; King MD
    J Phys Chem A; 2019 Aug; 123(32):6937-6947. PubMed ID: 31099570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastable polymorph of etoposide with higher dissolution rate.
    Shah JC; Chen JR; Chow D
    Drug Dev Ind Pharm; 1999 Jan; 25(1):63-7. PubMed ID: 10028419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structures and physicochemical properties of amisulpride polymorphs.
    Zhang WP; Chen DY
    J Pharm Biomed Anal; 2017 Jun; 140():252-257. PubMed ID: 28371719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.